IV Paracetamol vs IV Morphine vs Placebo in Sciatalgia

NCT ID: NCT02504996

Last Updated: 2015-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Siatalgia is one of the main symptoms related to emergency department presentations. Patients with sciatalgia are seeking for immediate pain relief and little known regarding the pain management of these patients in emergency department. This study aim to trial the effect of intravenous paracetamol and morphine in patients presented with sciatalgia to emergency department.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Siatalgia is one of the main symptoms related to emergency department presentations. Patients with sciatalgia are seeking for immediate pain relief and little known regarding the pain management of these patients in emergency department. Neuronal compression is the main cause of pain in sciatalgia rather than inflammation which also differ sciatalgia from the other type of pains in emergency department. Sciatalgia is a kind of neuralgia and there is not so much option in the pain management of these patients. Intravenous paracetamol and morphine is commonly used analgesics in various kind of pain in emergency department. So, this study aim to trial the effect of intravenous paracetamol and morphine in patients presented with sciatalgia to emergency department.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sciatica

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Paracetamol

1 g intravenous paracetamol (Perfalga, Bristol Myers) in 100 ml saline with a rapid infusion.

Group Type ACTIVE_COMPARATOR

Paracetamol

Intervention Type DRUG

1 g paracetamol via intravenous route in 100 ml normal saline

morphine

0.1 mg/kg morphine in 100 ml saline with a rapid infusion.

Group Type ACTIVE_COMPARATOR

morphine

Intervention Type DRUG

0.1 mg/kg morphine via intravenous route in 100 ml normal saline

placebo

100 ml saline

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Intravenous 100 ml normal saline

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paracetamol

1 g paracetamol via intravenous route in 100 ml normal saline

Intervention Type DRUG

morphine

0.1 mg/kg morphine via intravenous route in 100 ml normal saline

Intervention Type DRUG

Placebo

Intravenous 100 ml normal saline

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Perfalgan Morfin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with pain radiating to the sciatic nerve path
* Pain within the last one week
* Patients with positive straight leg raise
* Patients over 21 and lower than 65 years old

Exclusion Criteria

* Pain score lower than 40 mm in visual analogue scale score
* Neurological deficit
* Allergy to the study drugs
* Unstable vital signs
* History of malignancy or rheumatological diseases or arthritis
* History of chronic pain syndrome
* Receiving pain killer, steroid, anti-depressant, anti-convulsant and musculorelaxant within the last six hours.
* Drug or alcohol addiction
* Pregnancy or breast feeding
* Fewer more than 37.9 Celsius degrees.
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pamukkale University

OTHER

Sponsor Role collaborator

Antalya Training and Research Hospital

OTHER_GOV

Sponsor Role collaborator

University of Gaziantep

OTHER

Sponsor Role collaborator

Ataturk University

OTHER

Sponsor Role collaborator

Akdeniz University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cenker Eken

Associate Proffesor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mustafa Serinken, MD

Role: STUDY_CHAIR

Pamukkale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pamukkale University Hospital

Denizli, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cenker Eken, MD

Role: CONTACT

00905321593948

Mustafa Serinken, MD

Role: CONTACT

00905052991497

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aysel Özkan

Role: primary

00902582961758

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

70178

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.